Aspira Women’s Health Inc (NASDAQ: AWH)’s stock price has dropped by -12.10 in relation to previous closing price of 0.10. Nevertheless, the company has seen a loss of -37.21% in its stock price over the last five trading days. prnewswire.com reported 2025-03-12 that Full Year 2024 Net Revenue Increased 8% Year-over-Year to $562 million Full Year 2024 Adjusted EBITDA 1 Increased 9% Year-over-Year to $116 million Second Full Year of Positive Cash from Operations and Positive Free Cash Flow 2 Company Ended Q4 2024 with $88 Million of Cash and Cash Equivalents NEW YORK, March 12, 2025 /PRNewswire/ – Ascend Wellness Holdings, Inc. (“AWH” or the “Company”) (CSE: AAWH.U) (OTCQX: AAWH), a vertically integrated multi-state cannabis operator focused on bettering lives through cannabis, today reported its financial results for the fourth quarter and full year ended December 31, 2024. Financial results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and all currency is in U.S. dollars.
Is It Worth Investing in Aspira Women’s Health Inc (NASDAQ: AWH) Right Now?
The 36-month beta value for AWH is also noteworthy at 1.99. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for AWH is 12.63M, and at present, short sellers hold a 11.94% of that float. The average trading volume of AWH on March 24, 2025 was 4.20M shares.
AWH’s Market Performance
The stock of Aspira Women’s Health Inc (AWH) has seen a -37.21% decrease in the past week, with a -61.28% drop in the past month, and a -88.28% fall in the past quarter. The volatility ratio for the week is 13.70%, and the volatility levels for the past 30 days are at 21.41% for AWH. The simple moving average for the past 20 days is -45.53% for AWH’s stock, with a -89.86% simple moving average for the past 200 days.
Analysts’ Opinion of AWH
Many brokerage firms have already submitted their reports for AWH stocks, with Cantor Fitzgerald repeating the rating for AWH by listing it as a “Overweight.” The predicted price for AWH in the upcoming period, according to Cantor Fitzgerald is $4 based on the research report published on January 12, 2022 of the previous year 2022.
Truist, on the other hand, stated in their research note that they expect to see AWH reach a price target of $12. The rating they have provided for AWH stocks is “Buy” according to the report published on March 29th, 2021.
Cantor Fitzgerald gave a rating of “Overweight” to AWH, setting the target price at $10 in the report published on January 29th of the previous year.
AWH Trading at -71.16% from the 50-Day Moving Average
After a stumble in the market that brought AWH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.69% of loss for the given period.
Volatility was left at 21.41%, however, over the last 30 days, the volatility rate increased by 13.70%, as shares sank -60.05% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -88.28% lower at present.
During the last 5 trading sessions, AWH fell by -37.21%, which changed the moving average for the period of 200-days by -96.50% in comparison to the 20-day moving average, which settled at $0.1614. In addition, Aspira Women’s Health Inc saw -87.53% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AWH starting from Sandford Nicole, who purchase 9,493 shares at the price of $2.42 back on May 31 ’24. After this action, Sandford Nicole now owns 70,596 shares of Aspira Women’s Health Inc, valued at $22,973 using the latest closing price.
Stock Fundamentals for AWH
Current profitability levels for the company are sitting at:
- -1.89 for the present operating margin
- 0.58 for the gross margin
The net margin for Aspira Women’s Health Inc stands at -1.65. The total capital return value is set at 24.02. Equity return is now at value -701.30, with -220.48 for asset returns.
Based on Aspira Women’s Health Inc (AWH), the company’s capital structure generated -5.67 points at debt to capital in total, while cash flow to debt ratio is standing at -6.79. The debt to equity ratio resting at -0.85. The interest coverage ratio of the stock is -849.1.
Currently, EBITDA for the company is -16.49 million with net debt to EBITDA at -0.0. When we switch over and look at the enterprise to sales, we see a ratio of 0.17. The receivables turnover for the company is 7.15for trailing twelve months and the total asset turnover is 1.88. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.75.
Conclusion
In summary, Aspira Women’s Health Inc (AWH) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
